期刊文献+

外用钙调磷酸酶抑制剂治疗面部脂溢性皮炎 被引量:2

Topical calcineurin inhibitors in the treatment of facial seborrheic dermatitis
原文传递
导出
摘要 脂溢性皮炎是一种常见的炎症性皮肤病,以红斑、鳞屑、不同程度瘙痒为特征,好发于皮脂腺分泌旺盛部位,给患者的生活、工作带来影响.由于其具有慢性、复发性的特点,更需要一种安全有效的、可以长期使用的治疗手段.过去,脂溢性皮炎的治疗主要为抗真菌药、角质剥脱剂和糖皮质激素.近年,外用免疫调节剂成为慢性炎症性皮肤病的新型治疗方法.多项脂溢性皮炎的临床研究表明,钙调磷酸酶抑制剂,如他克莫司、吡美莫司治疗面部脂溢性皮炎安全有效. Seborrheic dermatitis is a common inflammatory skin condition characterized by erythema,scaling and pruritus with a predilection for areas rich in sebaceous glands. It affects patients' quality of life to an extent. Since it is a chronic and recurrent disease, there is a strong need for safe alternatives for its longterm management. In the past, antifungals, topical corticosteroids and keratolytics were the mainstay of its therapy. Now topical calcineurin inhibitors provide a safe alternative treatment for it. It has been demonstrated that such calcineurin inhibitors as pimecrolimus and tacrolimus are effective and safe in the treatment of facialseborrheic dermatitis.
出处 《国际皮肤性病学杂志》 2010年第3期140-142,共3页 International Journal of Dermatology and Venereology
关键词 皮炎 脂溢性 他克莫司 吡美莫司 Dermatitis,seborrheic Tacrolimus Pimecrolimus
  • 相关文献

参考文献20

  • 1Gupta AK,Madzia SE,Batra R.Etiology and management of seborrheic dermatitis.Dermatology,2004,208 (2):89-93.
  • 2Szepietowski JC,Reich A,Wesolowska-Szepietowska E,et al.Quality of life in patients suffering from seborrheic dermatitis:influence of age,gender and education level.Mycoses,2009,52(4):357-363.
  • 3DeAngelis YM,Gemmer CM,Kaczvinsky JR,et al.Three etiologic eacets of dandruff and seborrheic dermatitis:malassezia fungi,sebaceous lipids,and individual sensitivity.J Investig Dermatol Symp Proc,2005,10(3):295-297.
  • 4Elewski BE,Abramovits W,Kempers S,et al.A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.J Drugs Dermatol,2007,6(10):1001-1008.
  • 5Piérard GE,Ausma J,Henry F,et al.A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.Dermatology,2007,214 (2):162-169.
  • 6Tajima M,Sugita T,Nishikawa A,et al.Molecular analysis of Malassezia microflora in seborrheic dermatitis patients:comparison with other diseases and healthy subjects.J Invest Dermatol,2008,128(2):345-351.
  • 7Zouboulis CC,Degitz K.Androgen action on human skin from basic research to clinical significance.Exp Dermatol,2004,13 (Suppl4):5-10.
  • 8Ro BI,Dawson TL.The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of soborrheic dermatitis and dandruff.J Investig Dermatol Symp Proc,2005,10(3):194-197.
  • 9Faergemann J,Bergbrant IM,Dohse M,et al.Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis:characterization of inflammatory cells and mediators in the skin by immunohistochemistry.Br J Dermatol,2001,144(3):549-556.
  • 10Grassberger M,Baumruker T,Enz A,et al.A novel anti-inflammatory drug,SDZ ASM 981,for the treatment of skin diseases:in vitro pharmacology.Br J Dermatol,b 1999,141(2):264-273.

同被引文献17

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部